CLYM vs ZURA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

CLYM

54.3
AI Score
VS
CLYM Wins

ZURA

51.8
AI Score

Investment Advisor Scores

CLYM

54score
Recommendation
HOLD

ZURA

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLYM ZURA Winner
Net Income -13.72M -24.22M CLYM
Operating Income -15.21M -25.50M CLYM
ROE -9.3% -23.9% CLYM
ROA -9.0% -10.6% CLYM
Total Assets 152.37M 228.64M ZURA
Cash 8.36M 225.59M ZURA
Current Ratio 27.86 19.33 CLYM
Free Cash Flow -14.56M -18.94M CLYM

Relative Price Performance (Last 90 Days)

CLYM 1M: -10.5% · 3M: +34.0% ZURA 1M: +8.5% · 3M: +6.9%

Current Technical Phase

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.1 · Price: $11.90

ZURA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.4% over 20 days), RSI 55

RSI (14): 54.6 · Price: $5.43

Fundamentals Snapshot

Metric CLYM ZURA
Market Cap
Forward P/E -10.6 -9.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -0.77 -1.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.